Stay updated on VX-659 Combo in F/MF CF: Clinical Trial
Sign up to get notified when there's something new on the VX-659 Combo in F/MF CF: Clinical Trial page.

Latest updates to the VX-659 Combo in F/MF CF: Clinical Trial page
- ChecktodayChange DetectedA site-wide NIH transition notice was added above the ClinicalTrials.gov 403 error page, and the footer revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedKey study documents and site/location details were removed from the page, reducing access to the study's design information and the list of participating sites.SummaryDifference17%

- Check35 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects an updated document revision on the page.SummaryDifference0.0%

- Check42 days agoChange DetectedTel Litwinsky, Israel was added as a recruitment site and Qiryat Krinitzi, Israel was removed, altering the geographic footprint of participating centers in Israel.SummaryDifference0.0%

- Check49 days agoChange DetectedA new site in Qiryat Krinitzi, Israel was added and Tel Litwinsky, Israel was removed from the study locations; the page revision tag updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

Stay in the know with updates to VX-659 Combo in F/MF CF: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-659 Combo in F/MF CF: Clinical Trial page.